Related Experiment Videos

Aggressive intracranial teratocarcinoma with ventriculoperitoneal shunt metastases

T M Kuzel¹, A B Benson, A M Gurley

¹Northwestern University Medical School, Chicago, Illinois 60611.

The American Journal of Medicine

|June 1, 1989

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Nivolumab plus relatlimab and nivolumab plus ipilimumab for patients with advanced renal cell carcinoma: results from the open-label, randomised, phase II FRACTION-RCC trial.

ESMO open·2024

The consensus Immunoscore in phase 3 clinical trial (N0147) and impact on patient management decisions.

Oncoimmunology·2020

Acquired Resistance to Poly (ADP-ribose) Polymerase Inhibitor Olaparib in BRCA2-Associated Prostate Cancer Resulting From Biallelic BRCA2 Reversion Mutations Restores Both Germline and Somatic Loss-of-Function Mutations.

JCO precision oncology·2019

Level of evidence used in recommendations by the National Comprehensive Cancer Network (NCCN) guidelines beyond Food and Drug Administration approvals.

Annals of oncology : official journal of the European Society for Medical Oncology·2019

Attitudinal barriers to participation in oncology clinical trials: factor analysis and correlates of barriers.

European journal of cancer care·2014

Temsirolimus combined with sorafenib in hepatocellular carcinoma: a phase I dose-finding trial with pharmacokinetic and biomarker correlates.

Annals of oncology : official journal of the European Society for Medical Oncology·2013

See all related articles